© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder
New OJIN topic explores substance use disorders
In September, OJIN: The Online Journal of Issues in Nursing published six new articles on the topic “Substance use disorders and related concerns: Perspectives from nurses.” Here are some highlights.
Tobacco use, a leading cause...
Treating pain while mindful of opioid risks
Nurses can help avoid negative effects of opioids while ensuring patient pain is managed.
Takeaways:
Pain management can be complicated by individual patients’ previous pain experiences, genetics, ability to cope with trauma, underlying mental health...
Opioid overdose in the community
You reverse an overdose in the community.
Takeaways:
Opioid use disorder can be seen in hospitals, outpatient clinics, and even in the community.
Bystander naloxone administration is an opportunity to treat victims of opioid overdose...
Make treatment accessible for opioid use disorder during the COVID-19 pandemic
During the current pandemic Americans are dealing with a complete or near complete disruption of everyday life. It is the same for persons with opioid use disorder (OUD), but they are far from the...
Dangers of digital media addiction
The World Health Organization as well as several tech companies are encouraging on-line gaming with discounts and slogans such as, "Play your part, play at home." With schools closed, children suddenly have more time...
Opioid-induced respiratory depression
Be prepared and know the risks.
Takeaways:
Risk factors for opioid-induced respiratory depression include impaired rental clearance, high opioid tolerance, and sleep apnea history.
Tools for assessing patient sedation levels include Richmond Agitation-Sedation Scale and...
New research on possible adverse events to cannabis
A new study recently published in the Journal of Cannabis Research examines the potential “acute adverse reactions” associated with cannabis use.
The study examined self-reported adverse reactions from 999 cannabis users and revealed that the...
Cannabinoid hyperemesis syndrome explained
Learn how to identify this frequently misdiagnosed condition.
Takeaways:
Cannabinoid hyperemesis syndrome is a growing but poorly understood healthcare concern within the rising number of chronic, habitual cannabis users in the United States.
Cannabinoid hyperemesis...
Who will care for society’s forgotten?
Editor's note: Theresa is a frequent contributor to the New York Times (NYT), and recently authored an Op-Ed on an issue that affects the public at large and the broader health care community. She covers...
Alcohol-related mortality rates on the rise
A new study published in Alcoholism Clinical & Experimental Research reveals that the amount of alcohol-related deaths in the United States has increased between 1999 and 2017.
The study examined death certificates of people 16+...
FDA issues warning letter for medication-assisted treatment for opioid use disorder
The U.S. Food and Drug Administration (FDA) recently issued a warning letter to Alkermes, Inc. due to misbranding on the drug Vivitrol, which is used to prevent opioid dependence relapse. The letter was issued...
Legalized recreational marijuana may increase risk for cannabis use disorder
A recent study from JAMA Psychiatry examines this question: Has legalization of recreational marijuana in the United States affected the rates of cannabis use disorder (CUD)?
The research was conducted through a repeated, cross-sectional, self-reported...
American Heart Association: E-cigarettes are not safe alternative
The American Heart Association (AHA) recently held its 2019 Scientific Sessions in Philadelphia PA. The sessions covered many topics, but one of the most impactful was a session on e-cigarettes and their adverse health...
